TY  - GEN
AU  - Holmes,F A
AU  - Jones,S E
AU  - O'Shaughnessy,J
AU  - Vukelja,S
AU  - George,T
AU  - Savin,M
AU  - Richards,D
AU  - Glaspy,J
AU  - Meza,L
AU  - Cohen,G
AU  - Dhami,M
AU  - Budman,D R
AU  - Hackett,J
AU  - Brassard,M
AU  - Yang,B B
AU  - Liang,B C
TI  - Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy-induced neutropenia: a multicenter dose-finding study in women with breast cancer
SN  - 0923-7534
PY  - 2003///0109
KW  - Adult
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Confidence Intervals
KW  - Docetaxel
KW  - Dose-Response Relationship, Drug
KW  - Doxorubicin
KW  - Drug Administration Schedule
KW  - Drug Therapy, Combination
KW  - Drug-Related Side Effects and Adverse Reactions
KW  - Female
KW  - Filgrastim
KW  - Follow-Up Studies
KW  - Granulocyte Colony-Stimulating Factor
KW  - Humans
KW  - Injections, Subcutaneous
KW  - Middle Aged
KW  - Neutropenia
KW  - chemically induced
KW  - Paclitaxel
KW  - Polyethylene Glycols
KW  - Probability
KW  - Recombinant Proteins
KW  - Reference Values
KW  - Taxoids
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/annonc/mdf130
ER  -